Categories
Agriculture Economics & Trade Health Care Law & Regulation Politics & Society

Bacteria-hopping gene found in China could enable worldwide antibiotic resistance

Scientists in China have discovered that a gene enabling resistance to the sole remaining fully functioning class of antibiotics, colistin, is widespread in bacteria carried by both pigs and people in southern China–and can be transferred from one strain of bacteria to another, The Guardian reported, citing the journal Lancet Infectious Diseases. China is one […]

Categories
Health Care Politics & Society

Chinese prisoner organs still used in transplants despite reform pledge

Organs from prisoners on death row are still being used for transplants in China despite a pledge by a health official that the practice would end as of January 1 of this year, The New York Times reported, citing doctors and local media. Prisoners have been relabeled as citizens, enabling Chinese officials to include them […]

Categories
Business Practice Columns & Interviews Economics & Trade Employment & Education Health Care Law & Regulation Manufacturing Politics & Society Property

Q&A: David Bandurski on China's urban villages and the complications of urbanization

Dragons in Diamond Village

Categories
Energy & Environment Health Care Law & Regulation Politics & Society

Liaoning province smothered by smog in winter's first airpocalypse

Levels of carcinogenic particulate in the air of Liaoning’s provincial capital of Shenyang reportedly reached 56 times the levels considered safe by the World Health Orgnization on Sunday, and air in the city remained hazardous late Monday as even state media reported on the smog’s fallout, The Guardian reported. Yang Shenjia, who works at the Liaoning […]

Categories
Health Care Law & Regulation Tech, Media & Telecom

Authorities launch three-year pilot program to facilitate new drug approvals

The China Food and Drug Administration on Thursday announced a three-year pilot program, effective immediately, that will allow research and development outfits in ten regions to seek approvals for new drugs, a privilege currently enjoyed only by drug manufacturers, Reuters reported, citing a statement on the administration’s website. Current rules make it difficult for research-based […]